Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134114) titled 'Single-Arm, Multicenter, Phase II Exploratory Clinical Study of Paclitaxel Polymer Micelles for Injection Combined with Bevacizumab in the Treatment of Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer' on Oct. 10.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Recurrent ovarian cancer
Intervention:
1:Paclitaxel Polymer Micelles for Injection Combined with Bevacizumab for Once-Weekly Therapy
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2024-12-31 ...